$IBIO Dr. Linda Armstrong - Pfizer Sr. Director of Medical Affairs Dr. Alexander Kropotova - Pfizer Director & Head of Global Clinical Respiratory & Analgesics Pfizer Breakthrough Growth Initiative will Invest Up To $500-Mil. Across a Portfolio of Clinical-Stage Biotechnology Companies: twitter.com/trendspider/sta... Pfizer's funding is "non-controlling equity funding" meaning there's no strings attached. And with IBIO publicly stating in their recent 10K being leery about taking government funding due to regulatory compliance, regulatory controls, reporting, and monitoring issues - there are a few dots here to these new IBIO Board Members and Scientific Committee members than meets the eye. Just sayin.........
  • 13
13 Likes